Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience
- 31 December 1996
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 16 (1) , 61-73
- https://doi.org/10.1016/s0169-5002(96)00612-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancerLung Cancer, 1995
- A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancerLung Cancer, 1994
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals of Oncology, 1994
- Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in miceAnti-Cancer Drugs, 1993
- Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1992
- Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.Journal of Clinical Oncology, 1991
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958